| Code | 43566 | ||||||||||
| MA number | 76/0303/01-S | ||||||||||
| Product Form: | emu inf 3x2400 ml (vak Biofin) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Fresenius Kabi AB, Sweden | ||||||||||
| Therapeutic Class: | 76 - INFUNDIBILIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 05.10.2001 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_KABIVEN PERIPHERAL_08.2024.pdf
|
| SPC: |
SPC_KABIVEN PERIPHERAL_08.2024.pdf
|
| Safety feature | No |
| Data update: | 19.12.2019 |
